Page 11 - Platform Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clinicians say people with Alzheimer's could flock to a costly new drug made by Biogen. That could make it harder to develop better treatments.

They Have Alzheimer's. This Clinical Trial May Be a Last Hope 23 Apr, 2021 05:00 AM 7 minutes to read Michael Gross, a lifelong Yankees fan, was unnerved when he forgot the name of one of the team's former managers. Photo / Jackie Molloy / New York Times Michael Gross, a lifelong Yankees fan, was unnerved when he forgot the name of one of the team's former managers. Photo / Jackie Molloy / New York Times New York Times By: Gina Kolata Despite the urgent need for treatments to slow or stop Alzheimer's disease, finding patients for clinical trials has been difficult and frustrating. Pa...

This Alzheimer’s drug made from seaweed got approved in China. Now it’s being tested in N.J. Updated Mar 01, 2021; Posted Mar 01, 2021 New Jersey adults with mild to moderate Alzheimer’s are being recruited for a study involving a promising drug derived from seaweed that’s already approved for treatment of Alzheimer’s in China. Facebook Share A new drug extracted from seaweed and inspired by traditional Chinese medicine has come to the United States, where researchers hope it will provide the breakthrough in Alzheimer’s treatment that has eluded us for nearly two decades. The dr...

Share Biogen has announced a new multiyear research study on cognitive decline that will be conducted using the Apple Watch and iPhone. The observational study is being conducted in collaboration with Apple, according to the announcement, and is set to kick off later this year. The project's primary goal is to establish digital biomarkers for monitoring long-term cognitive performance and to spot early signs of mild cognitive impairment (MCI). Biogen said it will be enrolling "young and aging adults" into its virtual study. The company said it has designed the project's consent form to k...

VPF & National Endowment for Democracy call for tech solutions to protect Nigerians’ human rights during COVID-19 response Ventures Platform Foundation (VPF), the social impact arm of Ventures Platform Hub, has launched a call for applications for its latest incubation programme, Gov Labs – a 12-week programme for tech solutions implementing accountability and transparency within the Nigerian government’s COVID-19 response. Created with support from the National Endowment for Democracy (NED), the new initiative will support Civil Society Organizations from across Nigeria as they build i...